あなたはここにいる：ホーム > お知らせ > 企業動向 > 2016 Recombinant Pro...
著者： アップロード：2016-11-01 閲読回数：
China Pharmaceutical University and Hefei Chaohu Economic Development Zone successfully co-hosted the “2016 Recombinant Protein and Antibody Drug R&D Seminar” at Shenye Holiday Inn Hot Spring Resort recently. Medicilon congratulated the successful hosting of the seminar and sincerely thanked all the colleagues and peers from the pharmaceutical industry who attended this seminar for their sharing. As one of the co-organizers, Medicilon received a lot of attentions!
During the seminar, the organizers invited a
number of well-known experts and scholars to conduct in-depth discussion and
communication with participants on various topics such as MAb and ADC pharmacokinetics and the
latest research progress and prospect
of Biologics, through presentations and panel discussions. It played a significant
role in promoting the Development of pharmaceutical industry.
Photos From the Seminar and Panel Discussion
Guozhen Xu, VP of Sinobioway Bioeconomy Group Co., LTD. hosted the opening ceremony
Dr. Min Wang, President of China Pharmaceutical
University, delivered the welcoming speech
Dr. Ji Li, Vice Chairman
of Pharmaceutical Society of Jiangsu Province, delivered a welcoming speech
Dr. Yuexi Li, Vice Chairman of Biochemistry and
Molecular Biology Society of Jiangsu Province, delivered a welcoming speech
Wenbo Cao, CEO of Sinobioway Bioeconomy
Group, delivered a welcoming speech
Professor Min Wang from China Pharmaceutical
University hosted the
academic symposium
Huiping Chen from CFDA Audit Center reported for the analysis of
common problems in biological products inspection
Dr. Xingchu Gu, VP of Medicilon’s Preclinical
Research, reported on preclinical safety evaluation of therapeutic
monoclonal antibody
Zongmin Wang, Director of Jiangsu
Province Food and Drug Administration Registry, explained on the Reform Policy
of Drug Examination and Approval
Dr. Chunlin Chen, CEO of Medicilon, hosted the
panel discussion
Professor Yu Liu (Left) and Professor Hanmei Xu
(Right) from China
Pharmaceutical University
hosted the panel discussion
Professor Zichun Hua from Nanjing University
reported on long-term effects of protein drugs
Professor Chunmin Rao from National Institute of
Food and Drug Control reported on recombinant and antibody
drug quality control research
Professor Min Wang from China
Pharmaceutical University
reported on development of
monoclonal antibody in China
Dr. Xiangyang Zhu,
General Manager of Huabo Biopharm, reported on the progress
antibody drugs research
Dr. Wenzhi Tian from ImmuneOnco shared the
experience on antibody drug R & D
Dr. Juan Zhang, Vice Professor of China Pharmaceutical University, reported on the research of anti-tumor angiogenesis antibody JZB01
